Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China
Background: It has been reported that a fraction of recovered coronavirus disease 2019(COVID-19) patients have retested positive for SARS-CoV-2. Clinical characteristics and risk factors for retesting positive have not been studied extensively. Methods: In this retrospective, single-center cohort st...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | EClinicalMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537020302364 |
id |
doaj-192d469e883c458785a80b7945a8b5f3 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hua Ye Chengguang Zhao Lehe Yang Wenwen Yu Zhefeng Leng Yangjie Sun Zhongxiang Xiao Xie Zhang Long Zheng Xinxin Ye Legui Zheng Xiaoying Huang Yuanrong Dai Jifa Li |
spellingShingle |
Hua Ye Chengguang Zhao Lehe Yang Wenwen Yu Zhefeng Leng Yangjie Sun Zhongxiang Xiao Xie Zhang Long Zheng Xinxin Ye Legui Zheng Xiaoying Huang Yuanrong Dai Jifa Li Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China EClinicalMedicine |
author_facet |
Hua Ye Chengguang Zhao Lehe Yang Wenwen Yu Zhefeng Leng Yangjie Sun Zhongxiang Xiao Xie Zhang Long Zheng Xinxin Ye Legui Zheng Xiaoying Huang Yuanrong Dai Jifa Li |
author_sort |
Hua Ye |
title |
Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China |
title_short |
Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China |
title_full |
Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China |
title_fullStr |
Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China |
title_full_unstemmed |
Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China |
title_sort |
twelve out of 117 recovered covid-19 patients retest positive in a single-center study of china |
publisher |
Elsevier |
series |
EClinicalMedicine |
issn |
2589-5370 |
publishDate |
2020-09-01 |
description |
Background: It has been reported that a fraction of recovered coronavirus disease 2019(COVID-19) patients have retested positive for SARS-CoV-2. Clinical characteristics and risk factors for retesting positive have not been studied extensively. Methods: In this retrospective, single-center cohort study, we included adult patients (≥ 18 years old) diagnosed as COVID-19 in Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. All the patients were discharged before March 31, 2020, and were re-tested for SARS-CoV-2 RNA by real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) after meeting the discharge criteria. We retrospectively analyzed this cohort of 117 discharged patients and analyzed the differences between retest positive and negative patients in terms of demographics, clinical characteristics, laboratory findings, chest computed tomography (CT) features and treatment procedures. Findings: Compared with the negative group, the positive group had a higher proportion of patients with comorbidities (Odds Ratio(OR) =2·12, 95% Confidence Interval(CI) 0·48–9·46; p = 0·029), longer hospital stay (OR=1·21, 95% CI 1·07–1·36; p = 0·008), a higher proportion of patients with lymphocytopenia (p = 0·036), a higher proportion of antibiotics treatment (p = 0·008) and glucocorticoids treatment (p = 0·003). Multivariable regression showed increasing odds of positive SARS-CoV-2 retest after discharge associated with longer hospital stay (OR=1·22, 95% CI 1·08–1·38; p = 0·001), and lymphocytopenia (OR=7·74, 95% CI 1·70–35·21; p = 0·008) on admission. Interpretation: Patients with COVID-19 who met discharge criteria could still test positive for SARS-CoV-2 RNA. Longer hospital stay and lymphopenia could be potential risk factors for positive SARS-CoV-2 retest in COVID-19 patients after hospital discharge. Funding: Natural Science Foundation of Zhejiang Province, Medical Scientific Research Fund of Zhejiang Province, Wenzhou science and technology project |
url |
http://www.sciencedirect.com/science/article/pii/S2589537020302364 |
work_keys_str_mv |
AT huaye twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT chengguangzhao twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT leheyang twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT wenwenyu twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT zhefengleng twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT yangjiesun twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT zhongxiangxiao twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT xiezhang twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT longzheng twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT xinxinye twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT leguizheng twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT xiaoyinghuang twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT yuanrongdai twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina AT jifali twelveoutof117recoveredcovid19patientsretestpositiveinasinglecenterstudyofchina |
_version_ |
1725138993143611392 |
spelling |
doaj-192d469e883c458785a80b7945a8b5f32020-11-25T01:19:18ZengElsevierEClinicalMedicine2589-53702020-09-0126100492Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of ChinaHua Ye0Chengguang Zhao1Lehe Yang2Wenwen Yu3Zhefeng Leng4Yangjie Sun5Zhongxiang Xiao6Xie Zhang7Long Zheng8Xinxin Ye9Legui Zheng10Xiaoying Huang11Yuanrong Dai12Jifa Li13Department of Respiratory and Critical Care Medicine of Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, ChinaDepartment of Respiratory and Critical Care Medicine of Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, China; Department of Respiratory and Critical Care Medicine of the First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, Zhejiang China; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, ChinaDepartment of Respiratory and Critical Care Medicine of the First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, Zhejiang ChinaDepartment of Respiratory and Critical Care Medicine of Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, China; Department of Respiratory and Critical Care Medicine of the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, ChinaDepartment of Respiratory and Critical Care Medicine of the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, ChinaDepartment of Respiratory and Critical Care Medicine of Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, ChinaDepartment of Respiratory and Critical Care Medicine of Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, ChinaDepartment of Respiratory and Critical Care Medicine of Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, ChinaDepartment of Respiratory and Critical Care Medicine of Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, ChinaDepartment of Respiratory and Critical Care Medicine of Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, ChinaDepartment of Respiratory and Critical Care Medicine of Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, ChinaDepartment of Respiratory and Critical Care Medicine of the First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, Zhejiang China; Corresponding authors.Department of Respiratory and Critical Care Medicine of the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, China; Corresponding authors.Department of Respiratory and Critical Care Medicine of Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou 325600, Zhejiang, China; Corresponding authors.Background: It has been reported that a fraction of recovered coronavirus disease 2019(COVID-19) patients have retested positive for SARS-CoV-2. Clinical characteristics and risk factors for retesting positive have not been studied extensively. Methods: In this retrospective, single-center cohort study, we included adult patients (≥ 18 years old) diagnosed as COVID-19 in Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. All the patients were discharged before March 31, 2020, and were re-tested for SARS-CoV-2 RNA by real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) after meeting the discharge criteria. We retrospectively analyzed this cohort of 117 discharged patients and analyzed the differences between retest positive and negative patients in terms of demographics, clinical characteristics, laboratory findings, chest computed tomography (CT) features and treatment procedures. Findings: Compared with the negative group, the positive group had a higher proportion of patients with comorbidities (Odds Ratio(OR) =2·12, 95% Confidence Interval(CI) 0·48–9·46; p = 0·029), longer hospital stay (OR=1·21, 95% CI 1·07–1·36; p = 0·008), a higher proportion of patients with lymphocytopenia (p = 0·036), a higher proportion of antibiotics treatment (p = 0·008) and glucocorticoids treatment (p = 0·003). Multivariable regression showed increasing odds of positive SARS-CoV-2 retest after discharge associated with longer hospital stay (OR=1·22, 95% CI 1·08–1·38; p = 0·001), and lymphocytopenia (OR=7·74, 95% CI 1·70–35·21; p = 0·008) on admission. Interpretation: Patients with COVID-19 who met discharge criteria could still test positive for SARS-CoV-2 RNA. Longer hospital stay and lymphopenia could be potential risk factors for positive SARS-CoV-2 retest in COVID-19 patients after hospital discharge. Funding: Natural Science Foundation of Zhejiang Province, Medical Scientific Research Fund of Zhejiang Province, Wenzhou science and technology projecthttp://www.sciencedirect.com/science/article/pii/S2589537020302364 |